Sign up to save your podcasts
Or
Share Immunocore CEO: 3rd Big Pharma Eying Unique Cancer Targeting Tech
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Immunocore CEO: 3rd Big Pharma Eying Unique Cancer Targeting Tech
Immunocore is looking for more licensees for its cancer targeting technology following recent discovery and development deals with GSK and Genentech.
View all episodes
By William Reed Ltd
5
22 ratings
Immunocore is looking for more licensees for its cancer targeting technology following recent discovery and development deals with GSK and Genentech.